Davenport & Co
PDSB icon

Davenport & Co’s PDS Biotechnology PDSB Stock Holding History

Davenport & Co’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.51K Hold
10,000
– – ﹤0.01% 1389
2026
Q2 		$8.81K Hold
10,000
– – ﹤0.01% 1355
2026
Q1 		$6.05K Hold
10,000
– – ﹤0.01% 1302
2025
Q4 		$7.7K Buy
+10,000
New +$9.02K ﹤0.01% 1252

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Militia Capital Management
Militia Capital Management Austin, Texas $4B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Davenport & Co's PDSB Position: Q3 2026 in Review

Davenport & Co held its PDS Biotechnology (PDSB) position steady in Q3 2026 at 10,000 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

Davenport & Co first reported a position in PDSB in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.81K in Q2 2026. 48 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Davenport & Co held 10,000 shares of PDS Biotechnology worth $7.51K as of Q3 2026.
  • Davenport & Co left its PDS Biotechnology share count unchanged in Q3 2026.
  • PDS Biotechnology made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1389 holding.
  • Davenport & Co first reported a position in PDS Biotechnology in Q4 2025 and has held it in 4 quarters since.
  • Davenport & Co's PDS Biotechnology position peaked at $8.81K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.